IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharmaceutical Manufacture: Peptide Applications for Cardiovascular Therapies

2:30 PM MST | November 13, 2009 | Gary Hu, American Peptide Company

Gary Hu, American Peptide Company, VP Sales & Marketing A recent report by market and technology research firm Frost & Sullivan projected that the global peptide therapeutics market will be valued at nearly $2 billion by 2010, with Europe contributing more than a third, or $605 million, in a rapid development to meet the increasing need for new therapeutic approaches with peptides as active pharmaceutical ingredients (APIs). The peptide therapeutics market, according to Frost & Sullivan, is providing new commercial opportunities to life science...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa